The H19 rs217727 polymorphism has been shown to be associated with the risk of gastric cancer [20], breast cancer [18], and bladder cancer [19]; however, no significant association was observed between rs217727 and colorectal cancer risk [21] in the Chinese population. This evidence concerns the gene H19 and urinary bladder cancer.